Neurokinin 1 receptor gene polymorphism might be correlated with recurrence rates in endometriosis

Gynecological Endocrinology

Volumn 25, Issue 11, 2009, Pages 726-733

  Renner, Stefan P ^a   Ekici, Arif B ^b   Maihöfner, Christian ^a   Oppelt, Peter ^c   Thiel, Falk C ^a   Schrauder, Michael ^a   Uenluehan, Nesrin ^a   Bani, Mayada R ^a   Strissel, Pamela L ^a   Strick, Reiner ^a   Beckmann, Matthias W ^a   Fasching, Peter A ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c KEPLER UNIVERSITY HOSPITAL   (Austria)

Author keywords

Endometriosis; Neurokinin 1 receptor; NK1; NK1R; Substance p; TACR1

Indexed keywords

DNA; NEUROKININ 1 RECEPTOR;

CONFERENCE PAPER; DISEASE FREE SURVIVAL; DISEASE PREDISPOSITION; DNA ISOLATION; ENDOMETRIOSIS; FEMALE; HUMAN; PAIN ASSESSMENT; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; DISEASE-FREE SURVIVAL; ENDOMETRIOSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; KAPLAN-MEIERS ESTIMATE; MIDDLE AGED; PAIN; POLYMORPHISM, SINGLE NUCLEOTIDE; PREOPERATIVE PERIOD; PROPORTIONAL HAZARDS MODELS; RECEPTORS, NEUROKININ-1; RECURRENCE;

EID: 70350452032     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590903159631     Document Type: Conference Paper

References (42)

1. Mahmood TA, Templeton A. Prevalence and genesis of endometriosis. Hum Reprod 1991;6:544-549.
2. Moen MH, Schei B. Epidemiology of endometriosis in a Norwegian county. Acta Obstet Gynecol Scand 1997;76:559562.
3. Vigano P, Parazzini F, Somigliana E, Vercellini P. Endometriosis: epidemiology and aetiological factors. Best Pract Res Clin Obstet Gynaecol 2004;18:177-200.
4. Witz CA, Burns WN. Endometriosis and infertility: is there a cause and effect relationship? Gynecol Obstet Invest 2002; 53(Suppl 1):2-11.
5. Simpson JL, Elias S, Malinak LR, Buttram VC Jr, Heritable aspects of endometriosis. I. Genetic studies. Am J Obstet Gynecol 1980;137:327-331.
6. Simoens S, Hummelshoj L, D'Hooghe T. Endometriosis: cost estimates and methodological perspective. Hum Reprod Update 2007;13:395-404. (Pubitemid 47062831)
7. Allen C, Hopewell S, Prentice A. Non-steroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev 2005:CD004753.
8. Hoshiai H, Terakawa N. Novel therapeutic targets for GnRH analogues in the treatment of endometriosis and current approaches to optimizing GnRH analogue therapy. Introduction. Gynecol Obstet Invest 2008;66(Suppl l):l-2.
9. Nawathe A, Patwardhan S, Yates D, Harrison GR, Khan KS. Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis. BJOG 2008;115:818-822. (Pubitemid 351693018)
10. Redwine DB. Conservative laparoscopic excision of endometriosis by sharp dissection: life table analysis of reoperation and persistent or recurrent disease. Fertil Steril 1991;56:628-634.
11. Wheeler JM, Malinak LR. Recurrent endometriosis: incidence, management, and prognosis. Am J Obstet Gynecol 1983;146:247-253.
12. Evers JL, Dunselman GA, Land JA, Bouckaert PX. Is there a solution for recurrent endometriosis? Br J Clin Pract Suppl 1991;72:45-50; discussion 51-53.
13. Renner SP, Rix S, Lermann J, Hildebrandt T, Strissel P, Thiel FC, Oppelt P, Beckmann MW, Fasching PA. Preoperative pain and recurrence risk in patients with peritoneal endometriosis. Gynecol Endocrinol, in press.
14. Stratton P, Sinaii N, Segars J, Koziol D, Wesley R, Zimmer C, Winkel C, Nieman LK. Return of chronic pelvic pain from endometriosis after raloxifene treatment: a randomized controlled trial. Obstet Gynecol 2008;111:88-96.
15. Horowitz SH. The diagnostic workup of patients with neuropathic pain. Anesthesiol Clin 2007;25:699-708, v.
16. Evans S, Moalem-Taylor G, Tracey DJ. Pain and endometriosis. Pain 2007;132(Suppl 1):S22-S25.
17. Jarrell J, Brant R, Leung W, Taenzer P. Women's pain experience predicts future surgery for pain associated with endometriosis. J Obstet Gynaecol Can 2007;29:988-991.
18. Berkley KJ, Dmitrieva N, Curtis KS, Papka RE. Innervation of ectopic endometrium in a rat model of endometriosis. Proc Natl Acad Sci USA 2004;101:11094-11098. (Pubitemid 38989589)
19. Berkley KJJ Rapkin AJ, Papka RE. The pains of endometriosis. Science 2005;308:1587-1589.
20. Tokushige N, Markham R, Russell P, Fraser IS. Nerve fibres in peritoneal endometriosis. Hum Reprod 2006;21:3001-3007.
21. Anaf V, Chapron C, El Nakadi I, De Moor V, Simonart T, Noel JC. Pain, mast cells, and nerves in peritoneal, ovarian, and deep infiltrating endometriosis. Fertil Steril 2006;86: 1336-1343. (Pubitemid 44740094)
22. Moalem G, Tracey DJ. Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev 2006;51:240264. (Pubitemid 43902971)
23. Vaught JL. Substance P antagonists and analgesia: a review of the hypothesis. Life Sci 1988;43:1419-1431.
24. Abbadie C, Brown JL, Mantyh PW, Basbaum AL Spinal cord substance P receptor immunoreactivity increases in both inflammatory and nerve injury models of persistent pain. Neuroscience 1996;70:201-209. (Pubitemid 126755236)
25. Honor P, Menning PM, Rogers SD, Nichols ML, Basbaum AI, Besson JM, Mantyh PW. Spinal substance P receptor expression and internalization in acute, short-term, and longterm inflammatory pain states. J Neurosci 1999;19:7670-7678.
26. Henry JL. Substance P and inflammatory pain: potential of substance P antagonists as analgesics. Agents Actions Suppl 1993;41:75-87.
27. Hunt SP, Mantyh PW. The molecular dynamics of pain control. Nat Rev Neurosci 2001;2:83-91.
28. Patte-Mensah C, Kappes V, Freund-Mercier MJ, Tsutsui K, Mensah-Nyagan AG. Cellular distribution and bioactivity of the key steroidogenic enzyme, cytochrome P450side chain cleavage, in sensory neural pathways. J Neurochem 2003;86: 1233-1246. (Pubitemid 37025121)
29. Patte-Mensah C, Penning TM, Mensah-Nyagan AG. Anatomical and cellular localization of neuroactive 5 alpha/3 alphareduced steroid-synthesizing enzymes in the spinal cord. J Comp Neurol 2004;477:286-299. (Pubitemid 39136235)
30. Patte-Mensah C, Li S, Mensah-Nyagan AG. Impact of neuropathic pain on the gene expression and activity of cytochrome P450side-chain-cleavage in sensory neural networks. Cell Mol Life Sci 2004;61:2274-2284. (Pubitemid 39280124)
31. Lambert JJ, Belelli D, Peden DR, Vardy AW, Peters JA. Neurosteroid modulation of GABAA receptors. Prog Neurobiol 2003;71:67-80.
32. Bennett MI, Simpson KH. Gabapentin in the treatment of neuropathic pain. Palliât Med 2004;18:5-11.
33. Slonimski M, Abram SE, Zuniga RE. Intrathecal baclofen in pain management. Reg Anesth Pain Med 2004;29:269-276.
34. Patte-Mensah C, Kibaly C, Mensah-Nyagan AG. Substance P inhibits progesterone conversion to neuroactive metabolites in spinal sensory circuit: a potential component of nociception. Proc Natl Acad Sci USA 2005;102:9044-9049. (Pubitemid 40881075)
35. Orsal AS, Blois S, Labuz D, Peters EM, Schaefer M, Arck PC. The progesterone derivative dydrogesterone down-regulates neurokinin 1 receptor expression on lymphocytes, induces a Th2 skew and exerts hypoalgesic effects in mice. J Mol Med 2006;84:159-167. (Pubitemid 43201256)
36. Treloar SA, Wicks J, Nyholt DR, Montgomery GW, Bahlo M, Smith V, Dawson G, Mackay IJ, Weeks DE, Bennett ST, et al. Genomewide linkage study in 1,176 affected sister pair families identifies a significant susceptibility locus for endometriosis on chromosome 10q26. Am J Hum Genet 2005; 77:365-376. (Pubitemid 41192644)
37. Treloar SA, Zhao ZZ, Le L, Zondervan KT, Martin NG, Kennedy S, Nyholt DR, Montgomery GW. Variants in EMX2 and PTEN do not contribute to risk of endometriosis. Mol Hum Reprod 2007;13:587-594. (Pubitemid 47241912)
38. Zhao ZZ, Pollock PM, Thomas S, Treloar SA, Nyholt DR, Montgomery GW. Common variation in the fibroblast growth factor receptor 2 gene is not associated with endometriosis risk. Hum Reprod 2008;23:1661-1668. (Pubitemid 351809697)
39. Montgomery GW, Nyholt DR, Zhao ZZ, Treloar SA, PainterJN, Missmer SA, Kennedy SH, Zondervan KT. The search for genes contributing to endometriosis risk. Hum Reprod Update 2008;14:447-457.
40. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004;96:434-442. (Pubitemid 38443646)
41. Shakiba K, Bena JF, McGill KM, Minger J, Falcone T. Surgical treatment of endometriosis: a 7-year follow-up on the requirement for further surgery. Obstet Gynecol 2008;111: 1285-1292.
42. Sanger GJ. Neurokinin NK1 and NK3 receptors as targets for drugs to treat gastrointestinal motility disorders and pain. Br J Pharmacol 2004;141:1303-1312.